Literature DB >> 14404345

The central action of lignocaine and its effect on cardiac output.

F F KAO, U H JALAR.   

Abstract

Fifty-nine tests were performed on twenty-four anaesthetized dogs in a study of the effects of lignocaine on circulatory and respiratory functions. In single-dog experiments, it was shown that lignocaine (1 to 2 mg./kg. body weight) increased ventilation somewhat, but had no effect on O(2) consumption. Cardiac output was increased due to a rise in both heart rate and stroke volume. There was an elevation of arterial blood pressure. The central blood volume was increased, but central venous pressure, total peripheral resistance and the ventilationperfusion ratio were decreased. The increase in cardiac output after lignocaine was abolished both in decerebrate and in vagotomized dogs. In cross-circulation experiments with dogs, it was demonstrated that the primary site of action of lignocaine on cardiac output was central. The effect of lignocaine on cardiac output could be blocked by intravenous procaine.

Entities:  

Keywords:  CENTRAL NERVOUS SYSTEM/pharmacology; HEART/pharmacology; LIDOCAINE/pharmacology

Mesh:

Substances:

Year:  1959        PMID: 14404345      PMCID: PMC1481916          DOI: 10.1111/j.1476-5381.1959.tb00959.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  7 in total

1.  The dual nature of the action of succinylcholine on respiration in cross-circulated dogs.

Authors:  M H HARMEL; B D KING; F F KAO
Journal:  J Pharmacol Exp Ther       Date:  1958-12       Impact factor: 4.030

2.  Regulation of respiration during muscular activity.

Authors:  F F KAO
Journal:  Am J Physiol       Date:  1956-04

3.  Lidocaine in cardiac resuscitation from ventricular fibrillation.

Authors:  N L CARDEN; J E STEINHAUS
Journal:  Circ Res       Date:  1956-11       Impact factor: 17.367

4.  Respiratory and circulatory responses of anesthetized dogs to induced muscular work.

Authors:  F F KAO; L H RAY
Journal:  Am J Physiol       Date:  1954-11

5.  Contributions to the pharmacology and toxicology of xylocaine.

Authors:  S WIEDLING
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1952

6.  Intravenous use of procaine in general anesthesia.

Authors:  G W EDMONDS; W H COMER
Journal:  J Am Med Assoc       Date:  1949-11-12

7.  Cardiovascular effects of procaine and lidocaine (xylocaine) during general anesthesia.

Authors:  J R KIMMEY; J E STEINHAUS
Journal:  Acta Anaesthesiol Scand       Date:  1959       Impact factor: 2.105

  7 in total
  4 in total

1.  Use of lignocaine in treatment of cardiac arrhythmias.

Authors:  F H Spracklen; J J Kimerling; E M Besterman; J W Litchfield
Journal:  Br Med J       Date:  1968-01-13

Review 2.  Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

Authors:  C P Denaro; N L Benowitz
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

3.  Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography.

Authors:  M A Martin; N D Bax; G T Tucker; J W Ward
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

4.  Some pharmacological properties of o-methyl-alpha-propylaminopropioananilide, a new local anaesthetic.

Authors:  A ASTROM; N H PERSSON
Journal:  Br J Pharmacol Chemother       Date:  1961-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.